5-MTHF ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
337ホモシスチン尿症5

337. ホモシスチン尿症


臨床試験数 : 16 薬物数 : 19 - (DrugBank : 7) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 23
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2006-000614-21-AT
(EUCTR)
09/08/200716/06/2006A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuriaA multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria homocystinuria
MedDRA version: 8.1;Level: pref;Classification code 10020365
Product Name: Prefolic
INN or Proposed INN: 5-MTHF
Other descriptive name: IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino
Zambon Group S.p.ANULLNot RecruitingFemale: yes
Male: yes
22Hungary;United Kingdom;Italy;Austria
2EUCTR2006-000614-21-IT
(EUCTR)
11/12/200605/10/2007A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria - NDA multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria - ND Homocystinuria
MedDRA version: 6.1;Level: PT;Classification code 10020365
Trade Name: PREFOLIC 15*30CPR GASTROR 15MG
INN or Proposed INN: Detoxifying agents for antineoplastic treatment
ZAMBON GROUPNULLNot RecruitingFemale: yes
Male: yes
22Hungary;United Kingdom;Italy;Austria
3EUCTR2006-000614-21-HU
(EUCTR)
13/11/200615/08/2006A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuriaA multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria homocystinuria
MedDRA version: 8.1;Level: pref;Classification code 10020365
Product Name: Prefolic
INN or Proposed INN: 5-MTHF
Other descriptive name: IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino
Zambon Group S.p.ANULLNot RecruitingFemale: yes
Male: yes
22Phase 2Hungary;Slovakia;Austria;United Kingdom
4EUCTR2006-000614-21-GB
(EUCTR)
13/10/200620/09/2006A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuriaA multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria homocystinuria
MedDRA version: 8.1;Level: pref;Classification code 10020365
Trade Name: Prefolic
INN or Proposed INN: 5-MTHF
Other descriptive name: IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino
Zambon Group S.p.ANULLNot RecruitingFemale: yes
Male: yes
22Hungary;United Kingdom;Italy;Austria
5EUCTR2006-000614-21-SK
(EUCTR)
20/09/200612/07/2006A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuriaA multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria homocystinuria
MedDRA version: 8.1;Level: pref;Classification code 10020365
Product Name: Prefolic
INN or Proposed INN: 5-MTHF
Other descriptive name: IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino
Zambon Group S.p.ANULLNot RecruitingFemale: yes
Male: yes
22Phase 2Hungary;Slovakia;Austria;United Kingdom